9 reports

  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details
  • Cyclacel Pharmaceuticals Inc, Subsidiaries
  • Healthcare
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Cyclacel Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals Inc - Weaknesses
  • Cyclacel Pharmaceuticals Inc - Opportunities
  • Pharmaceutical
  • United States
  • Company Financials
  • Cyclacel Pharmaceuticals, Inc.
  • AML - Late-Stage Pipeline, 2015
  • R&D Strategies

Innate Pharma (2013).

  • Pharmaceutical
  • World
  • Demand
  • Market Size
  • Cyclacel Pharmaceuticals, Inc.
  • Valuation multiples (Cyclacel Pharmaceuticals, Inc.)
  • Valuation multiples (Cyclacel Pharmaceuticals, Inc.)
  • Pharmaceutical
  • United Kingdom
  • United States
  • Corporate Finance
  • Cyclacel Pharmaceuticals, Inc.
  • Astex Pharmaceuticals Inc
  • Cyclacel Pharmaceuticals Inc
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Cyclacel Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals Inc
  • Pipeline by Cyclacel Pharmaceuticals Inc, H2 2017
  • Cancer
  • Pharmaceutical
  • United States
  • Product Initiative
  • Cyclacel Pharmaceuticals, Inc.
  • Tragara Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals, Inc.
  • Cancer
  • Pathology
  • Pharmaceutical
  • Therapy
  • Cyclacel Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals, Inc.
  • Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2016
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Cyclacel Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals, Inc.
  • Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2016
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Cyclacel Pharmaceuticals, Inc.